Aixia Ma

机构：China Pharmaceutical University

发表论文 27 篇 · 总被引 363 次 · h-index 12

代表论文

Intraoperative venous congestion rather than hypotension is associated with acute adverse kidney events after cardiac surgery: a retrospective cohort study (2022 · British Journal of Anaesthesia · 被引 49)
Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis (2023 · Frontiers in Pharmacology · 被引 41)
A comparison of self-reported and proxy-reported health utilities in children: a systematic review and meta-analysis (2021 · Health and Quality of Life Outcomes · 被引 38)
Economic Evaluation of Sintilimab Plus Bevacizumab Versus Sorafenib as a First-line Treatment for Unresectable Hepatocellular Carcinoma (2022 · Advances in Therapy · 被引 36)
Cost-effectiveness analysis of sintilimab plus bevacizumab biosimilar compared with lenvatinib as the first-line treatment of unresectable or metastatic hepatocellular carcinoma (2022 · BMC Health Services Research · 被引 28)
The efficacy and safety of eravacycline compared with current clinically common antibiotics in the treatment of adults with complicated intra-abdominal infections: A Bayesian network meta-analysis (2022 · Frontiers in Medicine · 被引 22)